PD-Rx Pharmaceuticals, Inc. FDA Record
- Latest inspection VAI · Aug 20, 2026
- No warning letters matched by name
PD-Rx Pharmaceuticals, Inc. has 25 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "PD-Rx Pharmaceuticals, Inc." is on file.
- Latest recall
- D-0163-2025 · Class II · Dec 4, 2024
- Latest inspection
- Aug 20, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 25 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 4 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
PD-Rx Pharmaceuticals, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 1 | 0 |
| 2023 | 0 | 0 | 0 | 5 | 0 |
| 2022 | 1 | 0 | 0 | 3 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 7 | 0 |
| 2019 | 0 | 0 | 0 | 1 | 0 |
| 2018 | 0 | 0 | 0 | 2 | 0 |
| 2017 | 0 | 0 | 0 | 2 | 0 |
Reviewing PD-Rx Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check PD-Rx Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0163-2025 | Class II | DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma… | Dec 4, 2024 |
| D-0561-2023 | Class II | Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx… | Apr 6, 2023 |
| D-0560-2023 | Class II | Simvastatin USP 20 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx… | Apr 6, 2023 |
| D-0558-2023 | Class II | Simvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx… | Apr 6, 2023 |
| D-0557-2023 | Class II | Montelukast Sodium USP, 10 mg, 30 count-bottles, Rx only, Intas Pharm, Limited Ahmedabad 380 054… | Apr 6, 2023 |
| D-0559-2023 | Class II | Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals… | Apr 6, 2023 |
| D-1162-2022 | Class II | Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx… | Jun 6, 2022 |
| D-1161-2022 | Class II | Losartan Potassium Tablets, USP 25 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx… | Jun 6, 2022 |
| D-1163-2022 | Class II | Losartan Potassium Tablets, USP 100 mg, 90 Tablets bottles, Rx Only, Marketed and Packaged By: PD-Rx… | Jun 6, 2022 |
| D-0060-2021 | Class II | metformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127… | Oct 6, 2020 |
| D-0059-2021 | Class II | metformin HCL ER 500 mg, a) 30 tablets NDC: 72789-009-30; b) 60 tablets NDC: 72789-009-60; c) 90… | Oct 6, 2020 |
| D-0005-2021 | Class II | Nature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg… | Sep 17, 2020 |
| D-1333-2020 | Class II | metFORMIN HCL ER 500 mg, a) 30 tablets (NDC 72789-009-30); b) 60 tablets (NDC 72789-009-60); c) 90… | Jun 5, 2020 |
| D-1307-2020 | Class II | metFORMIN HCL ER USP 500 mg, a) 30 tablets (NDC: 43063-428-30); b) 60 tablets (NDC: 43063-428-60)… | Jun 5, 2020 |
| D-1276-2020 | Class II | Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b)… | May 15, 2020 |
| D-0826-2020 | Class II | ranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count… | Jan 10, 2020 |
| D-0341-2021 | Class II | Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK… | Mar 8, 2019 |
| D-1127-2018 | Class II | Doxycycline Hyclate USP Tablets, 100 mg packaged in a) 2-count bottles, NDC 55289-866-02; b) 6-count… | Aug 7, 2018 |
| D-0341-2018 | Class II | PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30… | Jan 25, 2018 |
| D-1118-2017 | Class III | Phentermine Capsules, 15 mg, a) 7-count bottle (NDC 55289-791-07), b) 14-count bottle ( NDC… | Aug 11, 2017 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 20, 2026 | Oklahoma City, OK | Drugs | Voluntary Action Indicated (VAI) | 1641825 |
| Nov 10, 2022 | Oklahoma City, OK | Drugs | Voluntary Action Indicated (VAI) | 1641825 |
| Dec 4, 2015 | Oklahoma City, OK | Drugs | Voluntary Action Indicated (VAI) | 1641825 |
| May 21, 2009 | Oklahoma City, OK | Drugs | No Action Indicated (NAI) | 1641825 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1641825 | Oklahoma City, OK | 4 | Aug 20, 2026 |
PD-Rx Pharmaceuticals, Inc. and the FDA: common questions
Has PD-Rx Pharmaceuticals, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "PD-Rx Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has PD-Rx Pharmaceuticals, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "PD-Rx Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect PD-Rx Pharmaceuticals, Inc.?
The most recent FDA inspection on file ended Aug 20, 2026 at Oklahoma City, OK and was classified VAI. FDA has 4 inspections of PD-Rx Pharmaceuticals, Inc. on file.
Has PD-Rx Pharmaceuticals, Inc. had an FDA recall?
Yes. PD-Rx Pharmaceuticals, Inc. has 25 FDA recalls on record. The most recent started Dec 4, 2024.
Need more than this page shows? Ask about PD-Rx Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.